Back to News
Market Impact: 0.2

Aurinia Pharmaceuticals' (AUPH) CEO Bought 815,000 Shares for $12.5 Million

Insider TransactionsCompany FundamentalsMarket Technicals & Flows

814,606 common shares were acquired for approximately $12.5 million at a weighted average price of $15.29 per share. The filing indicates a sizable share purchase, but the excerpt provides no additional operational or strategic context. Overall impact appears limited and primarily relevant as an insider transaction signal.

Analysis

814,606 common shares were acquired for approximately $12.5 million at a weighted average price of $15.29 per share. The filing indicates a sizable share purchase, but the excerpt provides no additional operational or strategic context. Overall impact appears limited and primarily relevant as an insider transaction signal.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.10